John Fox, MD, MHA, vice president of Clinical Transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's call to expand comprehensive genomic testing across several cancers.
John Fox, MD, MHA, vice president of cinical transformation at Spectrum Health, reacts to the National Comprehensive Cancer Network's (NCCN's) call to expand comprehensive genomic testing across several cancers.
Transcript
At the most recent NCCN Annual Meeting, guidelines called for expanded comprehensive molecular profiling across several cancers. Do these changes present new reimbursement challenges?
The NCCN has recommended that we do comprehensive molecular profiling on more and more cancer types. It’s fascinating because the cost of genomic profiling is now in the range of $2500 to $3000. If you look at the cost of the therapies we’re using, they may be, if you’re using a monoclonal antibody, $8000, $10,000, $15,000 a month, and if we’re using those in combination, it’s even more. So, if in fact those molecular profiles help better identify which patients are likely to respond to which therapies, it’s a good value, because they’re spending thousands, tens of thousands of dollars a month on treatment, that if ineffective, is a waste of dollars and a waste of resources and a cost to the patient.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More